ASSOCIATION OF PULMONARY HYPERTENSION WITH OUTCOMES IN PATIENTS WITH SYSTEMIC SCLEROSIS AND OTHER CONNECTIVE TISSUE DISORDERS: REVIEW AND META-ANALYSIS

被引:1
|
作者
Gegenava, Maka [1 ]
Gegenava, Tea [2 ]
机构
[1] Tbilisi State Med Univ, Dept Internal Med 2, GE-2023 Tbilisi, Georgia
[2] Tbilisi State Med Univ, Dept Internal Med 1, Tbilisi, Georgia
关键词
Pulmonary hypertension; Systemic Sclerosis; Systemic lupus erythematosus; ARTERIAL-HYPERTENSION; PREVALENCE; SURVIVAL;
D O I
10.36141/svdld.v41i1.14570
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and aim: Pulmonary hypertension (PH) is a frequent complication of connective tissue disorders (CTDs), with a major impact on the prognosis of the disease. The aim of our study was to perform a systemic review and meta -analysis of published literature evaluating survival function in patients with systemic sclerosis (SSc) with and without PH and to compare survival function between patients with SSc, systemic lupus erythematosus (SLE), other CTDs, and conditions associated with PH. Methods: The established protocol of the Cochrane Collaboration Steps and meta -analysis of observational studies in epidemiology recommendations (MOOSE) were used. Results: 7 studies, including 1470 SSc-PH patients and 1368 SSc patients without PH, and 4 studies, including 108 SLE-PH patients and 1288 SLE patients without PH, assessed survival function were selected. Six studies (including 777 SSc, 249 SLE, 90 idiopathic pulmonary arterial hypertension -IPAH (2 papers selected for the study with the old terminology of idiopathic pulmonary hypertension-IPH and idiopathic primary pulmonary hypertension IPP) and 29 primary Sjogren's syndrome patients) comparing survival function in different subgroups of patients with confirmed PH were included. SSc patients with PH showed the worst survival as compared to SSc patients without PH [OR (95% CI) 3.70 (2.42-5.67); p<0.00001]. The same pattern was observed in patients with SLE. SSc patients with PH were characterized by lower survival function compared to other reasons for PH, including SLE [OR (95% CI) 2.76 (1.95-3.91); p<0.00001]. Conclusions: Patients with SSc-PH are characterized by significantly lower survival function as compared to SSc patients without PH. Among the different entities of PH, SSc shows the worst survival, underlining prognostic significance of detection and evaluation of PH according to the currently established approach.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis
    Marieta P. Theodorakopoulou
    Ioanna Minopoulou
    Pantelis Sarafidis
    Vassilios Kamperidis
    Christodoulos Papadopoulos
    Theodoros Dimitroulas
    Afroditi K. Boutou
    Rheumatology International, 2021, 41 : 1045 - 1053
  • [22] Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis
    Lv, Tian-Tian
    Wang, Peng
    Guan, Shi-Yang
    Li, Hong-Miao
    Li, Xiao-Mei
    Wang, Bin
    Pan, Hai-Feng
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 (03) : 723 - 730
  • [23] Independent Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
    Barkhane, Zineb
    Nimerta, F. N. U.
    Zulfiqar, Sualeha
    Dar, Saleha
    Afzal, Muhammad Sohaib
    Zaree, Amna
    Adwani, Rahul
    Palleti, Sujith K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [24] Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis
    Liu, Yuqi
    Cheng, Zhen
    Zha, Bowen
    Chen, Xiaodong
    Gong, Zhiyu
    Ji, Lang
    Wei, Lingling
    LUPUS, 2023, 32 (11) : 1310 - 1319
  • [25] Pulmonary Hypertension in Interstitial Lung Disease A Systematic Review and Meta-Analysis
    Ang, Hui Li
    Schulte, Max
    Chan, Roseanne Kimberley
    Tan, Hann Hsiang
    Harrison, Amelia
    Ryerson, Christopher J.
    Khor, Yet Hong
    CHEST, 2024, 166 (04) : 778 - 792
  • [26] Prevalence and incidence of systemic sclerosis: A systematic review and meta-analysis
    Zhong, Lixian
    Pope, Melinda
    Shen, Ye
    Hernandez, Jose J.
    Wu, Lin
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (12) : 2096 - 2107
  • [27] Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients
    Koh, ET
    Lee, P
    Gladman, DD
    AbuShakra, M
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (10): : 989 - 993
  • [28] Effect of Obesity on Mortality in Pulmonary Hypertension-A Systematic Review and Meta-Analysis
    Reddy, Raju
    Kalra, Saminder Singh
    Alzghoul, Bashar
    Khan, Akram
    Zayed, Yazan
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (10)
  • [29] Acute decompensated pulmonary hypertension outcomes in pulmonary arterial hypertension patients: systematic review and meta-analysis of proportions
    Garcia, Marcos Vinicius Fernandes
    Nanah, Abdelrahman
    Caruso, Pedro
    HEART & LUNG, 2025, 70 : 57 - 64
  • [30] Diagnostic value of nailfold videocapillaroscopy in systemic sclerosis secondary pulmonary arterial hypertension: a meta-analysis
    Xia, Zhongbin
    Wang, Guiping
    Xiao, Huashi
    Guo, Shanshan
    Liu, Ying
    Meng, Fanru
    Liu, Dan
    Li, Guoqing
    Zong, Liang
    INTERNAL MEDICINE JOURNAL, 2018, 48 (11) : 1355 - 1359